Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-105101

Interim CEO & General Counsel gave up 17,702 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 41,669 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Exercise or conversion : show line 1 in the form +41,669 604,161 D
2026-09-01 Shares withheld for taxes : show line 2 in the form −17,702 $8.28 $146,573 586,459 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −41,669 83,338 D
Loading xslF345X06/tm2624648-3_4seq1.xml…